Management of osteoporosis in the aging male: Focus on zoledronic acid

Código QR

Management of osteoporosis in the aging male: Focus on zoledronic acid

Paul K Piper Jr1, Ugis Gruntmanis1,21Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX USA; 2North Texas Veterans Affairs Medical Center, Dallas, TX USAAbstract: Osteoporosis in the aging male remains an important yet under-recognized and undertrea...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Paul K Piper Jr, Ugis Gruntmanis
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Osteoporosis Aging Male zoledronic acid Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/e99d02c1bbae4937ba19d775b87ff477
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011)

Once-yearly zoledronic acid in hip fracture prevention
por: Oddom Demontiero, et al.
Publicado: (2009)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
por: Wang Z, et al.
Publicado: (2021)

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
por: Shi C, et al.
Publicado: (2018)

BFH-OSTM, a new predictive screening tool for identifying osteoporosis in elderly Han Chinese males
por: Lin J, et al.
Publicado: (2017)

A review of minodronic acid hydrate for the treatment of osteoporosis
por: Tanishima S, et al.
Publicado: (2013)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021)

Osteoporosis in the aging male: Treatment options
por: Stephen P Tuck, et al.
Publicado: (2008)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Federica Bellone, et al.
Publicado: (2021)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
por: Irene Lambrinoudaki, et al.
Publicado: (2008)

Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
por: Nagy EE, et al.
Publicado: (2020)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014)

Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke A, et al.
Publicado: (2017)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)

Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool
por: Lin JS, et al.
Publicado: (2016)

Comparison of three tools for predicting primary osteoporosis in an elderly male population in Beijing: a cross-sectional study
por: Zhang X, et al.
Publicado: (2018)

Identification of Aberrantly Expressed Long Non-Coding RNAs and Nearby Targeted Genes in Male Osteoporosis
por: Fei Q, et al.
Publicado: (2020)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
por: Ma Z, et al.
Publicado: (2016)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Raja Bobba, et al.
Publicado: (2007)

Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
por: İlhan B, et al.
Publicado: (2015)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Claudia Gagnon, et al.
Publicado: (2008)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009)

Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats
por: Chin KY, et al.
Publicado: (2014)

Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population
por: Xu J, et al.
Publicado: (2013)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009)

Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014)

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020)

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives
por: Lin X, et al.
Publicado: (2015)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan T, et al.
Publicado: (2013)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)

Eldecalcitol for the treatment of osteoporosis
por: Noguchi Y, et al.
Publicado: (2013)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
por: Victor G Vogel
Publicado: (2008)

Fracture liaison services: improving outcomes for patients with osteoporosis
por: Walters S, et al.
Publicado: (2017)

Teriparatide in the management of osteoporosis
por: Donald Bodenner, et al.
Publicado: (2008)

lncRNA GAS5 Is Upregulated in Osteoporosis and Downregulates miR-21 to Promote Apoptosis of Osteoclasts
por: Cong C, et al.
Publicado: (2020)

Effects of age on effect-site concentration of remifentanil for suppressing anesthetic emergence cough in male patients undergoing laparoscopic cholecystectomy
por: Kim HY, et al.
Publicado: (2018)